Manfred Beier
Overview
Explore the profile of Manfred Beier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
336
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Royer-Pokora B, Wruck W, Adjaye J, Beier M
PLoS One
. 2023 Jan;
18(1):e0270380.
PMID: 36689432
In order to get a better insight into the timing of WT1 mutant Wilms tumor development, we compared the gene expression profiles of nine established WT1 mutant Wilms tumor cell...
2.
Van Meenen D, Doege A, Alefeld E, Haase A, Beier M, Kiefer T, et al.
Int J Mol Sci
. 2022 Oct;
23(20).
PMID: 36293469
A disintegrin and metalloproteinase (ADAM) family proteins, acting as sheddases, are important factors in a number of pathologies, including cancer, and have been suggested as promising therapeutic targets. The study...
3.
Busch M, Haase A, Miroschnikov N, Doege A, Biewald E, Bechrakis N, et al.
Cancers (Basel)
. 2022 Feb;
14(3).
PMID: 35158945
Retinoblastoma (RB) is the most common childhood eye cancer. The expression of trefoil factor family peptide 1 (TFF1), a small secreted peptide, has been correlated with more advanced RB stages...
4.
Sproll K, Schorn L, Reising B, Schumacher S, Lommen J, Kubler N, et al.
Mol Oncol
. 2021 Oct;
16(2):333-346.
PMID: 34719102
Considering the limited information on the biology and molecular characteristics of disseminated tumor cells (DTCs) in head and neck squamous cell carcinoma (HNSCC), we examined the genomic alterations in DTCs...
5.
Royer-Pokora B, Busch M, Tenbusch S, Schmidt M, Beier M, Woods A, et al.
Cancers (Basel)
. 2020 Dec;
13(1).
PMID: 33379206
Purpose: mutant Wilms tumors represent a distinct subgroup, frequently associated with mutations. The genetic basis for the development of this subtype is currently not fully understood. Methods: Live mutant Wilms...
6.
Skowron M, Petzsch P, Hardt K, Wagner N, Beier M, Stepanow S, et al.
Sci Rep
. 2019 Oct;
9(1):14476.
PMID: 31597922
The DNA-damaging compound cisplatin is broadly employed for cancer chemotherapy. The mutagenic effects of cisplatin on cancer cell genomes are poorly studied and might even contribute to drug resistance. We...
7.
Royer-Pokora B, Beier M, Brandt A, Duhme C, Busch M, de Torres C, et al.
Cancer Med
. 2018 Mar;
7(4):1359-1368.
PMID: 29542868
Wilms tumors (WT) with WT1 mutations do not respond well to preoperative chemotherapy by volume reduction, suggesting resistance to chemotherapy. The histologic pattern of this tumor subtype indicates an intrinsic...
8.
Rausch V, Krieg A, Camps J, Behrens B, Beier M, Wangsa D, et al.
BMC Res Notes
. 2017 Nov;
10(1):560.
PMID: 29110683
Background: Mortality rates of pancreatic cancer remain high, which is mainly due to advanced disease and metastasis. We hypothesized that genomic copy number alterations are enriched in metastatic cells compared...
9.
Busch M, Metz K, Beier M, Biewald E, Dunker N
Retina
. 2017 Oct;
38(12):2422-2428.
PMID: 29016460
Purpose: Correlation of trefoil factor family 1 (TFF1) expression in retinoblastoma tumors with different clinical parameters to evaluate a potential involvement of TFF1 in tumor development and progression. Methods: A...
10.
Busch M, Grosse-Kreul J, Wirtz J, Beier M, Stephan H, Royer-Pokora B, et al.
Int J Cancer
. 2017 May;
141(3):549-560.
PMID: 28481041
Trefoil factor family (TFF) peptides have been shown to play a pivotal role in oncogenic transformation, tumorigenesis and metastasis by changing cell proliferation, apoptosis, migration and invasion behavior of various...